ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OMGA Omega Therapeutics Inc

2.58
-0.18 (-6.52%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Omega Therapeutics Inc OMGA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.18 -6.52% 2.58 10:00:00
Open Price Low Price High Price Close Price Previous Close
2.83 2.56 3.00 2.58 2.76
more quote information »

Recent News

Date Time Source Heading
23/4/202421:00GLOBEOmega Therapeutics to Present New Preclinical Data on..
09/4/202421:00GLOBEOmega Therapeutics Presents New Preclinical Data at AACR..
29/3/202400:15GLOBEOmega Therapeutics Reports Fourth Quarter and Full Year 2023..
06/3/202423:00GLOBEOmega Therapeutics Announces Two Poster Presentations at the..
10/2/202409:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202408:00EDGAR2Form 8-K - Current report
03/1/202408:05GLOBEOmega Therapeutics to Present at the 42nd Annual J.P. Morgan..
12/12/202308:00EDGAR2Form 8-K - Current report
05/12/202308:00GLOBEOmega Therapeutics to Participate in the H.C. Wainwright 4th..
28/11/202311:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202322:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
21/11/202308:00GLOBEOmega Therapeutics to Participate in the Piper Sandler 35th..
13/11/202323:00GLOBEOmega Therapeutics Showcases Bidirectional and Multiplexed..
09/11/202323:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:03EDGAR2Form 8-K - Current report
09/11/202323:00GLOBEOmega Therapeutics Reports Third Quarter 2023 Financial..
08/11/202308:00GLOBEOmega Therapeutics to Participate in The Jefferies London..
31/10/202322:00GLOBEOmega Therapeutics Presents New Preclinical Data..
16/10/202322:00GLOBEOmega Therapeutics Presents New Preclinical Data Supporting..
12/10/202307:00GLOBEOmega Therapeutics Announces Two Poster Presentations on..
05/10/202307:00GLOBEOmega Therapeutics to Present New Preclinical Data on..
27/9/202307:29EDGAR2Form 8-K - Current report
26/9/202321:00GLOBEOmega Therapeutics Announces Promising Preliminary Clinical..
26/9/202306:00GLOBEOmega Therapeutics to Host Conference Call to Discuss..
23/9/202307:10EDGAR2Form 8-K - Current report
22/9/202306:00GLOBEOmega Therapeutics to Participate in Two Upcoming Investor..
11/9/202320:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
30/8/202306:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202306:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/8/202321:03EDGAR2Form 8-K - Current report
29/8/202321:00GLOBEOmega Therapeutics Announces Updates to its Board of..
04/8/202307:13EDGAR2Form 8-K - Current report
04/8/202307:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/8/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202306:00GLOBEOmega Therapeutics Reports Second Quarter 2023 Financial..
14/7/202306:00EDGAR2Form 8-K - Current report
13/7/202306:01EDGAR2Form 8-K - Current report
12/7/202321:00GLOBEOmega Therapeutics Appoints Chris Schade to its Board of..
01/6/202321:00GLOBEOmega Therapeutics to Participate in Two Upcoming Investor..
31/5/202322:30GLOBEAshvattha Therapeutics Expands Leadership Team with..
31/5/202321:00GLOBEOmega Therapeutics Presents New Preclinical Data..
16/5/202320:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..

Your Recent History

Delayed Upgrade Clock